Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab.

Nyckelord

Alberta

Angioplasty; Transluminal; Percutaneous Coronary

Antibodies; Monoclonal/administration & dosage

Anticoagulants/administration & dosage

Belgium

Drug Administration Schedule

Drug Therapy; Combination

Emergency Treatment

Enoxaparin/administration & dosage

Female

Fibrinolytic Agents/*administration & dosage

Germany

Heparin/administration & dosage

Humans

Immunoglobulins; Fab/administration & dosage

Italy

Male

Middle Aged

Myocardial Infarction/mortality/*therapy

Netherlands

North Carolina

Platelet Glycoprotein GPIIb-IIIa Complex/*antagonists & inhibitors

Recurrence

Spain

Surgical Procedures; Elective

Survival Analysis

Sweden

Tissue Plasminogen Activator/administration & dosage

Treatment Outcome

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)